Expert Analysis - Opinion

Gilead Ruling Signals That Innovating Can Lead To Liability

By Gary Myers · February 6, 2024, 5:15 PM EST

The Court of Appeal of the State of California ruled last month that a drug manufacturer can be liable for negligence for its delay in introducing an improved version of its...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Featured Stories

Healthcare Deals This Week: Sanofi, Summit Therapeutics, F2G, More No Photo Available

Andrew Strickler

A trio of IPOs that hit the market on the same day and a handful of funding rounds lead this week's notable deals in the healthcare industry.

Henrietta Lacks' Family Still Seeks Justice For 'Immortal' Cells No Photo Available

Dan McKay

Seven decades have passed since a doctor at a Baltimore hospital took, without permission, a sample of cells from a Black woman suffer... (more story)

HIMSS Legal Chief Reflects On Balancing AI, Legal Risk No Photo Available

Ian Thoms

As artificial intelligence finds itself taking up a large role in the healthcare industry, experts say they're watching closely to see... (more story)